A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: satisfy (78), calm (44), soothe (11), ease (133)

MyelomaCTDa28CyclophosphamideDexamethasoneThalidomideAttenuated(CTDa)Ver1

Description
Chemotherapy Protocol MULTIPLE MYELOMA CTDa (28)-CYCLOPHOSPHAMIDE-DEXAMETHASONE-THALIDOMIDE (ATTENUATED) (CTDa-28) There are multiple versions of this protocol in use
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaCTDa28CyclophosphamideDexamethasoneThalidomideAttenuatedCTDaVer1.pdf

Whooping cough study - volunteers information sheet

Description
Chief Investigator Professor R. C. Read Southampton National Institute for Health Research Wellcome Trust Clinical Research Facility Southampton Centre for Biomedica
Url
/Media/Southampton-Clinical-Research/Patient-information-sheet/Whooping-cough-study-volunteers-information-sheet.docx

Talimogene laherparepvec (T-VEC)

Description
Chemotherapy Protocol SKIN CANCER Talimogene laherparepvec (T-VEC) Regimen • Skin – Talimogene laherparepvec (T-VEC) Indication • Talimogene laherparepvec (T-VEC) is recommended
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Talimogene-laherparepvec-T-VEC.pdf

Capecitabine-Irinotecan

Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and IRINOTECAN (XELIRI) Regimen • Colorectal Cancer– Capecitabine-Irinotecan (XELIRI) Indication • Treatment of advanced colorectal cancer • WHO
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Irinotecan.pdf

Familial adenomatous polyposis (FAP) - patient information

Description
This booklet is for people attending the clinical genetics service with a personal or family history of familial adenomatous polyposis (FAP
Url
/Media/UHS-website-2019/Patientinformation/Genetics/Familial-adenomatous-polyposis-FAP-1429-PIL.pdf

Acalabrutinib

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Acalabrutinib • CLL – Acalabrutinib Indication • First-line treatment of chronic lymphocytic leukaemia (CLL) prior to EU
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Acalabrutinib.pdf

Appendix B - VZIG risk assessment and prescription form

Description
Varicella zoster Immunoglobulin for post-exposure prophylaxis (PEP)Please note that UHS Pharmacy will issue VZIG only
Url
/Media/UHS-website-2019/Docs/Post-Exposure-Prophylaxis-Policy/AppendixB-VZIGRiskAssessmentandPrescriptionForm.pdf

mini-RCHOP 21

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-RITUXIMAB-VINCRISTINE (mini-RCHOP 21) Regimen   Lymphoma – mini-RCHOP (21)-Cyclophosphamide-Doxorubicin-PrednisoloneRituximab-Vincristine Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/mini-RCHOP-21.pdf

ACCORD-2 example sub-protocol

Description
CONFIDENTIAL ACCORD-2-002 - Sub protocol for Bemcentinib (Amendment 01) TITLE PAGE Master Protocol Title: ACCORD-2: A Multicentre, Seamless, Phase 2 Adaptive
Url
/Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-example-sub-protocol.pdf
1 to 9 of 9